LIFEVANTAGE CORP Equity Securities without Readily Determinable Fair Value, Amount
LIFEVANTAGE CORP (LFVN) had Equity Securities without Readily Determinable Fair Value, Amount of $0 as of 2023-06-30, per its 10-K filed 2023-08-28.
Discontinued › Notes
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2023-08-28
- 2023-06-30: Equity Securities without Readily Determinable Fair Value, Amount $0.00.
- 2022-06-30: Equity Securities without Readily Determinable Fair Value, Amount $0.00; Equity Securities without Readily Determinable Fair Value, Amount as first filed $2.20M.
- 2022-03-31: Equity Securities without Readily Determinable Fair Value, Amount $2.20M.
- 2021-12-31: Equity Securities without Readily Determinable Fair Value, Amount $2.20M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount | Equity Securities without Readily Determinable Fair Value, Amount as first filed |
|---|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-08-28 | |
| 2022-06-30 | $0.00 10-K · filed 2023-08-28 | $2.20M 10-Q · filed 2022-11-02 |
| 2022-03-31 | $2.20M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $2.20M 10-Q · filed 2022-02-01 | |
| 2021-09-30 | $2.20M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.20M 10-K · filed 2022-08-23 | |
| 2021-03-31 | $2.20M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $2.20M 10-Q · filed 2021-02-02 | |
| 2020-09-30 | $2.20M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $2.20M 10-K · filed 2021-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |